These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Witek RP, Stone WC, Karaca FG, Syn WK, Pereira TA, Agboola KM, Omenetti A, Jung Y, Teaberry V, Choi SS, Guy CD, Pollard J, Charlton P, Diehl AM. Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126 [Abstract] [Full Text] [Related]
14. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet. Luo XY, Takahara T, Kawai K, Fujino M, Sugiyama T, Tsuneyama K, Tsukada K, Nakae S, Zhong L, Li XK. Am J Physiol Gastrointest Liver Physiol; 2013 Dec 01; 305(12):G891-9. PubMed ID: 24136786 [Abstract] [Full Text] [Related]
15. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Sahai A, Malladi P, Melin-Aldana H, Green RM, Whitington PF. Am J Physiol Gastrointest Liver Physiol; 2004 Jul 01; 287(1):G264-73. PubMed ID: 15044174 [Abstract] [Full Text] [Related]